The Possible Immunological Pathways for the Variable Immunopathogenesis of COVID—19 Infections among Healthy Adults, Elderly and Children

Novel Coronavirus, COVID-19 discovered in December, 2019 in Wuhan, China started a world-wide epidemic. It is not clear till now what is the pathogenesis of this virus infection in human or the exact strategies of host immune response in combating this novel threat to human beings. However, morbidit...

Full description

Saved in:
Bibliographic Details
Published inElectronic Journal of General Medicine Vol. 17; no. 4; p. em202
Main Authors Abdulamir, Ahmed S., Hafidh, Rand R.
Format Journal Article Book Review
LanguageEnglish
Published East Sussex 21.03.2020
Online AccessGet full text

Cover

More Information
Summary:Novel Coronavirus, COVID-19 discovered in December, 2019 in Wuhan, China started a world-wide epidemic. It is not clear till now what is the pathogenesis of this virus infection in human or the exact strategies of host immune response in combating this novel threat to human beings. However, morbidity and mortality of COVID-19 infections vary widely from asymptomatic, mild to deadly critical. Strangely, children were found to be protected from severe or deadly critical infections, while elderly and immunocompromised adults are most affected badly by this virus. It is necessary to disclose the possible viral and host interactions that lead to such variable morbid effects among patients of COVID-19 infections.
ISSN:2516-3507
2516-3507
DOI:10.29333/ejgm/7850